Results 81 to 90 of about 13,016 (186)

BCR::ABL1 Tyrosine Kinase Inhibitors During Pregnancy, a Disproportionality Analysis of Vigibase

open access: yesClinical Pharmacology &Therapeutics, Volume 118, Issue 3, Page 705-714, September 2025.
Tyrosine kinase inhibitors (TKIs) targeting BCR::ABL1 have greatly improved the survival of patients with chronic myeloid leukemia (CML), and their teratogenicity appears as an important factor for individuals of childbearing potential. This study aims to investigate pregnancy and fetal/newborn adverse outcomes resulting from exposure to BCR::ABL1‐TKIs
Aurélie Cabannes‐Hamy   +13 more
wiley   +1 more source

Feasibility of Multiplex Cytokine Profiling in Preterm Labor: Towards Biomarker Discovery. [PDF]

open access: yesBiology (Basel)
Llano R   +7 more
europepmc   +1 more source

Cooperative Breeding as a Likely Early Catalyst of Human Evolution

open access: yesEvolutionary Anthropology: Issues, News, and Reviews, Volume 34, Issue 3, September 2025.
ABSTRACT Unlike any other great ape, humans give birth to large, secondarily altricial babies, show precocial social development, have bigger brains that require a long maturation period, and engage in cooperative breeding (CB). These traits, which characterize the human adaptive complex, are intricately linked and must have mutually reinforced each ...
Judith M. Burkart   +3 more
wiley   +1 more source

A Protocol for the Development and Validation of the Postpartum Specific Anxiety Scale—Preterm Birth [PSAS‐PTB] and the Postpartum Specific Anxiety Scale—Neonatal Intensive Care Unit [PSAS‐NICU]

open access: yesInternational Journal of Methods in Psychiatric Research, Volume 34, Issue 3, September 2025.
ABSTRACT Objectives To describe the development and the methodology for validation of a new scale for postpartum anxiety for mothers of preterm infants, and a ‘Velcro’ sub‐scale of the Postpartum Specific Anxiety Scale for use with mothers who have had infants admitted to the Neonatal Intensive Care Unit.
Semra Worrall   +4 more
wiley   +1 more source

β3‐Adrenoceptor Agonist Effects on the Urinary Bladder Beyond Detrusor Relaxation

open access: yesNeurourology and Urodynamics, Volume 44, Issue 7, Page 1498-1502, September 2025.
ABSTRACT Aims β3‐Adrenoceptor agonists such as mirabegron or vibegron reach pharmacokinetic steady‐state within a few days. However, maximum improvements in symptoms of the overactive bladder syndrome are reached at time points later than 4 weeks, that is, detrusor smooth muscle relaxation cannot fully explain clinical effects.
Martin C. Michel   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy